Keapstone Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$3.12M
- Investors
-
3
Keapstone Therapeutics General Information
Description
Developer of a novel series of small-molecule activators of the medical pathway designed to serve Parkinson's patients. The company's molecule prevents KEAP1 from interacting with Nrf2, which improves redox balance and mitochondrial function, promotes autophagy, and limits inflammation, enabling people with Parkinson's disease to live a better life.
Contact Information
Website
www.keapstone.comCorporate Office
- The Innovation Centre
- 217 Portobello
- Sheffield S1 4DP
- England, United Kingdom
Corporate Office
- The Innovation Centre
- 217 Portobello
- Sheffield S1 4DP
- England, United Kingdom
Keapstone Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 24-Sep-2018 | $3.12M | Completed | Startup | ||
| 1. University Spin-Out | 01-Feb-2017 | Completed | Startup |
Keapstone Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Keapstone Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Keapstone Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Parkinson's UK | Corporation | Minority | ||
| University of Sheffield Endowment | Limited Partner | Minority | ||
| The University of Sheffield | University |
Keapstone Therapeutics FAQs
-
When was Keapstone Therapeutics founded?
Keapstone Therapeutics was founded in 2017.
-
Where is Keapstone Therapeutics headquartered?
Keapstone Therapeutics is headquartered in Sheffield, United Kingdom.
-
What is the size of Keapstone Therapeutics?
Keapstone Therapeutics has 2 total employees.
-
What industry is Keapstone Therapeutics in?
Keapstone Therapeutics’s primary industry is Drug Discovery.
-
Is Keapstone Therapeutics a private or public company?
Keapstone Therapeutics is a Private company.
-
What is Keapstone Therapeutics’s current revenue?
The current revenue for Keapstone Therapeutics is .
-
How much funding has Keapstone Therapeutics raised over time?
Keapstone Therapeutics has raised $3.12M.
-
Who are Keapstone Therapeutics’s investors?
Parkinson's UK, University of Sheffield Endowment, and The University of Sheffield have invested in Keapstone Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
